Unlocking an “Aladdin’s cave” of Medicare data is the key to saving Australia’s celebrated health system and changing ...

For the second time in 16 months, Unity Biotechnology is restructuring its operations. The developer of drugs to treat diseases of aging is cutting its headcount in half to ensure its cash reserves ...

UNITY Biotechnology, Inc. reported its financial results for the first quarter of 2025, highlighting the 24-week and partial 36-week topline data from its Phase 2b ASPIRE study in diabetic macular ...

UNITY Biotechnology, Inc. has announced that it will present data from its ASPIRE Phase 2B study on its senolytic candidate, UBX1325, targeting diabetic macular edema at the upcoming ARVO 2025 Annual ...

The competition in the data industry is intensifying as Databricks Inc. vies for dominance. The company has thrown down the gauntlet by open-sourcing its Unity Catalog. Strechay and Gilbert were ...

Unity's Vector AI platform is accelerating growth and margins, making the stock a bullish opportunity. Read here for more ...

Unity said it has acquired Pixyz Software, a provider of 3D data preparation and optimization software. The price wasn’t disclosed. With Pixyz’s portfolio of products, creators in many industries can ...

LAS VEGAS--(BUSINESS WIRE)--Today Unity Technologies (https://unity3d.com/), creator of the world’s most widely used real-time 3D development platform, announced ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Today, Databricks kicked off its annual ...

Unity Biotechnology, Inc. (NASDAQ:UBX) stock plummeted on Monday after the company released results from its latest study. The Phase 2b ASPIRE clinical trial of intravitreal UBX1325 involed patients ...

The new offering spans digital twins for industries, synthetic data generation, interactive 3D experiences, reality solutions, and games powered by Unity ...